Zahrieh, D.; Satele, D.; Smith, E.M.L.; Loprinzi, C.L.; Le-Rademacher, J.
Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months. Cancers 2022, 14, 1212.
https://doi.org/10.3390/cancers14051212
AMA Style
Zahrieh D, Satele D, Smith EML, Loprinzi CL, Le-Rademacher J.
Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months. Cancers. 2022; 14(5):1212.
https://doi.org/10.3390/cancers14051212
Chicago/Turabian Style
Zahrieh, David, Daniel Satele, Ellen M. Lavoie Smith, Charles L. Loprinzi, and Jennifer Le-Rademacher.
2022. "Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months" Cancers 14, no. 5: 1212.
https://doi.org/10.3390/cancers14051212
APA Style
Zahrieh, D., Satele, D., Smith, E. M. L., Loprinzi, C. L., & Le-Rademacher, J.
(2022). Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months. Cancers, 14(5), 1212.
https://doi.org/10.3390/cancers14051212